Apellis
Apellis is seeking a passionate and talented marketer for the role of Associate Director, US Professional Education (Prof Ed) on our Geographic Atrophy (GA) Marketing Team. It is an outstanding opportunity to make a significant impact for Eyecare Professionals (ECPs) and the company that launched the first FDA approved therapy to treat Geographic Atrophy, an irreversible disease.
Headquarters
Waltham, Massachusetts, United States
Company Size
501-1000 employees
Founded
2008
Apellis Pharmaceuticals is a global biopharmaceutical company that pioneers targeted C3 therapies to treat diseases driven by excessive activation of the complement cascade, with programs focused in hematology, ophthalmology, and nephrology. The company has received three product approvals in four years and focuses on conditions such as geographic atrophy and rare diseases. Apellis has been acquired by Biogen; visitors are directed to biogen.com for more information.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Apellis.
73% above the average for this role
Regional Marketer, Sleep (West Region)
Axsome Therapeutics
Marketing Senior Manager, Peer-to-peer (Remote)
lifelancer
Area Business Manager, Portland, OR
Acadia Pharmaceuticals Inc.
Associate Director, U.S. HCP Marketing
Regeneron Pharmaceuticals
Global HCP Marketing Lead, Duvakitug (IBD)
Sanofi
Associate Director, US HCP Peer-to-Peer (P2P) Marketing, gMG & NMOSD, Rare Neurology
AstraZeneca